# FRESENIUS KABI USA LLC hires WILEY REIN LLP (Pharmacy)

**Score:** 45/100

| Field | Value |
|---|---|
| Client | FRESENIUS KABI USA LLC |
| Client description | Pharmaceutical manufacturing |
| Client state | IL |
| Lobbying firm | WILEY REIN LLP |
| Firm state | DC |
| Issue areas | Pharmacy |
| Specific matters disclosed | H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act; H.R. 6485/S. 43, Skinny Labels, Big Savings Act; Biosimilar industry issues |
| Registered | 2026-10-14 |

## Why this score
- Specific matters disclosed.

Source: U.S. Senate and House Lobbying Disclosure Act (LDA) filings via lda.gov; Colorado Secretary of State, NYC City Clerk eLobbyist and City of Chicago Board of Ethics lobbying data (https://lda.gov/filings/public/filing/5b7ee230-ab1e-42c3-9a2d-fa826195f437/print/). Last refreshed: 2026-11-04T21:45:03.363Z.
From public Lobbying Disclosure Act registrations (lda.gov) and Colorado, New York City and City of Chicago lobbying disclosures. Organization level only: we never list lobbyist, CEO or contact names, and clients whose name reads as a person are left out. Chicago amounts are lobbyist compensation reported for the quarter, summed by client. A registration reports intent to lobby; it is not evidence of wrongdoing.